Search Results

Displaying Results 1251-1275 of 2612 "'DNA'"

Dec 08, 2025, 05:35 ET Exosomes Market Led by North America with 53% Revenue Share and Global Market Size Set to Surpass USD 2B by 2030, Says Mordor Intelligence

Spectrometry  By Biomolecule Type  Non-coding RNA (miRNA, lncRNA)Proteins & PeptidesLipidsmRNADNA FragmentsBy Application  Diagnostics  Cancer  Neuro-degenerative Diseases  Infectious

More news about: Mordor Intelligence Private Limited


Dec 08, 2025, 01:36 ET GC Biopharma Ships First Doses of World's First Recombinant Anthrax Vaccine, 'BARYTHRAX inj.'

- First anthrax vaccine developed using recombinant DNA technology- Annual production capacity of up to 10 million doses at GC Biopharma's facility YONGIN, South Korea, Dec. 8, 2025

More news about: GC Biopharma


Dec 07, 2025, 12:01 ET Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Years

proteins that are 8x more active than normal. These genetic instructions remain in the target cells, but generally do not become a part of a person's own DNA. Once delivered, the new genetic instructions allow the cellular machinery to produce stable levels of factor IX.Important Safety Information (ISI)What

More news about: CSL


Dec 05, 2025, 11:00 ET Cue Chef Innovation Launches Cube O1: The World's First Thermal-AI Cooking Assistant

Privacy, and Community1. Cue: Capturing Your Culinary DNAWhen you cook a dish with Cube O1, it captures the recipe's essential fingerprint—the exact time, temperature, and key transition points. This "Cooking DNA" liberates your recipe from being tied to one specific pot or stove.

More news about: Cue Chef Innovation


Dec 05, 2025, 10:00 ET Preliminary Data from FANSS Study Show Potential for Blood-Based Lung Cancer Detection in Non-Smoking Population

discovery that cancer cells are more chaotic than normal cells and, when they die, leave behind tell-tale patterns and characteristics of cell-free DNA (cfDNA) fragments in the blood. The DELFI platform applies advanced machine-learning technology to whole-genome sequencing data to assess individuals'

More news about: DELFI Diagnostics


Dec 05, 2025, 08:33 ET Ginkgo Bioworks Selected by PNNL to Deliver a Modular, High‑Throughput Phenotyping Platform for DOE's M2PC

BOSTON, Dec. 5, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced it has been awarded by the

More news about: Ginkgo Bioworks


Dec 04, 2025, 17:40 ET MDA SPACE ANNOUNCES OFFERING OF C$250 MILLION SENIOR UNSECURED NOTES DUE 2030

vision into an achievable mission – bringing to bear a one-of-a-kind mix of experience, engineering excellence and wide-eyed wonder that's been in our DNA since day one. For those who dream big and push boundaries on the ground and in the stars to change the world for the better, we'll take you there. For

More news about: MDA Space


Dec 04, 2025, 16:54 ET Human Longevity Expands $1M Cancer Pledge to Redefine Early Detection and Prevention of Colon Cancer

approach was demonstrated by a recent client experience. The patient had a normal colonoscopy, yet both the GRAIL blood test and the Cologuard stool DNA test returned positive results. Follow-up evaluation revealed cancer in the appendix, a region near the colon not always fully evaluated during routine

More news about: Human Longevity, Inc.


Dec 04, 2025, 15:17 ET AlidaBio Introduces the EpiPlex™ Duo-Mod™ Service for Concurrent m6A and Inosine Mapping with Integrated RNA Expression Profiling

revealing immune dysregulation in autoimmune disease, early oncogenic signaling, and RNA misprocessing in neurodegeneration, insights often missed by DNA, RNA expression, or protein analyses alone.The EpiPlex Duo-Mod Service applies AlidaBio's proximity barcoding and enrichment chemistry to profile

More news about: Alida Biosciences


Dec 04, 2025, 12:04 ET CASIS to Manage the International Space Station National Laboratory Through 2030

the next generation of researchers, engineers, and explorers. For example, the annual Genes in Space™ research competition launches student-designed DNA experiments to the space station, and these projects have

More news about: International Space Station National Lab


Dec 04, 2025, 12:00 ET Dessert Holdings Partners with Synoptek to Drive Digital Transformation and Growth

and Platform Development, Customer and Employee Experience, and Cybersecurity. With growth, ownership, inclusiveness, and philanthropy embedded in its DNA, Synoptek is committed to delivering improved business results and unmatched service to all its stakeholders.

More news about: Synoptek


Dec 04, 2025, 10:00 ET Southern Arizona Survey Shows Strong Support for Copper Mining and Workforce Education

the University of Arizona School of Mining Engineering & Mineral ResourcesAs one of the founding schools in 1885, mining is in the DNA of the University of Arizona. But the industry and the world it serves have evolved greatly since those early years. Responsible practices, health and

More news about: Arizona Mining Association


Dec 04, 2025, 09:05 ET MDA SPACE AWARDED INITIAL CONTRACT BY CANADIAN SPACE AGENCY FOR RADARSAT CONSTELLATION MISSION REPLENISHMENT SATELLITE

vision into an achievable mission – bringing to bear a one-of-a-kind mix of experience, engineering excellence and wide-eyed wonder that's been in our DNA since day one. For those who dream big and push boundaries on the ground and in the stars to change the world for the better, we'll take you there. For

More news about: MDA Space


Dec 04, 2025, 08:30 ET Powered By Innovation: Murata to Showcase Intelligent System Technologies for Mobility, Wellness, and Connectivity at CES 2026

non-invasively, continuously, and intelligently. Solutions on display include:Molecular Analysis Platform 1, 2,3 (15-minute DNA/RNA analysis)Vios Monitoring System (continuous hospital-grade telemetry and remote ECG)Application example of the 3D substrate Multilayer

More news about: Murata Electronics North America, Inc.


Dec 04, 2025, 03:53 ET Dessert Holdings Partners with Synoptek to Drive Digital Transformation and Growth

and Platform Development, Customer and Employee Experience, and Cybersecurity. With growth, ownership, inclusiveness, and philanthropy embedded in its DNA, Synoptek is committed to delivering improved business results and unmatched service to all its stakeholders.

More news about: Synoptek


Dec 03, 2025, 21:00 ET X-Design Takes #1 on Product Hunt with AI Agent That Democratizes Branding for Local Businesses

memory. It serves as an always-on brand manager, ensuring that everything from a shop's logo to its Instagram posts retains the brand's unique "Visual DNA" without requiring users to repeat themselves.Solving the "Visual Consistency" Struggle for SMBsBuilt on insights from over 500

More news about: X-Design


Dec 03, 2025, 17:31 ET Hemophilia A Market to Exhibit Growth at a CAGR of 2.9% During the Forecast Period (2025-2034) Owing to the Rising Hemophilia Prevalence, Strong Uptake of New Drugs, and Emergence of High-cost Gene Therapies | DelveInsight

A utilizing an Adeno-associated Virus (AAV) vector derived from the AAVhu37 serotype. It is a non-replicating AAV vector carrying a single-stranded DNA genome that encodes a B-domain–deleted FVIII, driven by a liver-specific promoter and enhancer sequence optimized for strong transgene expression. The

More news about: DelveInsight Business Research, LLP


Dec 03, 2025, 11:11 ET Straightforward Guide to Funding Featured in LibraryBub Selection for December

Blewett ISBN: 979-8339626329It's All about Your Team: One Team. Shared Success by Michael Giaramita ISBN: 978-1637352670Leadership DNA: shaping a thriving business culture by Alinka Rutkowska, Deepak Bhootra, Brandon C. Blewett et al. ASIN: B0CZG4GNFJNavigating B2B: master

More news about: LibraryBub


Dec 03, 2025, 11:00 ET Fin Raises $17M to Launch Stablecoin Product for High-Value Payments

crypto—simple, intuitive, and ready for real-world users," said Ryan Barney, Partner at Pantera Capital. "Fin brings that same product DNA to high-value global payments, stepping into a massive global opportunity."About Fin

More news about: Fin


Dec 03, 2025, 10:42 ET Astrin Biosciences Launches Certitude™ Breast, the First Non-Imaging Breast Cancer Detection Test

to mammograms, detecting specific signatures of cancer in women with dense breast tissue far earlier than visible on imaging or in circulating tumor DNA."I've seen firsthand how far screening has come — and where gaps remain. Mammography remains our most powerful population-level screening tool,

More news about: Astrin Biosciences


Dec 03, 2025, 10:17 ET Globant presents a new edition of Converge, its annual thought-provoking event, with global leaders sharing how to move from AI ideation to execution

technology, and human ingenuity to deliver real business outcomes. Attendees will gain actionable insights on how to embed AI into their organizations' DNA and unlock the next chapter of growth and efficiency.The agenda: learning from real-world cases and leading the changeConversations

More news about: GLOBANT


Dec 03, 2025, 09:53 ET Globant presents a new edition of Converge, its annual thought-provoking event, with global leaders sharing how to move from AI ideation to execution

technology, and human ingenuity to deliver real business outcomes. Attendees will gain actionable insights on how to embed AI into their organizations' DNA and unlock the next chapter of growth and efficiency.The agenda: learning from real-world cases and leading the change

More news about: GLOBANT


Dec 03, 2025, 09:16 ET From BlackRock to Boutique: Inflection's First Year Rewriting the Wealth Management Playbook

Inflection.Kunz firmly believes they are well-aligned for clients and the environment ahead: "Being employee-owned and grounded in single family office DNA gives us long-term alignment. It's a structure built to serve our clients for generations."Families navigating complexity, preparing for a wealth

More news about: Inflection Capital Management. LLC


Dec 03, 2025, 09:00 ET Quadriga BioSciences Announces Encouraging Interim Phase II Results of LAT1-targeted QBS72S in Breast Cancer Patients with Leptomeningeal Disease

brain barrier (BBB) as well as to selectively target numerous types of rapidly growing cancer cells. Once inside the cell QBS72S causes double-stranded DNA breaks resulting in cell death. Most aggressive cancers express high LAT1, which is commonly associated with poor prognoses.

More news about: Quadriga BioSciences, Inc.


Dec 03, 2025, 08:59 ET Vanguard Launches Target Retirement Lifetime Income Trusts

highest insurance ratings.i Updates on product design and availability will be announced throughout 2026."Lifetime income is in TIAA's DNA—the company was founded in 1918 by Andrew Carnegie specifically to provide guaranteed lifetime income to American workers," said Colbert Narcisse, Chief

More news about: Vanguard


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.